-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $125

Benzinga·07/10/2026 14:13:37
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $130 to $125.